Loading…
* Free cash flow = OCF − net investing outflow (the filings carry no standalone capex line).
Dividends declared (per SOCE filings): FY2022 0 · FY2023 0 · FY2024 0
Operates in Healthcare Services — Other healthcare services. Per the activity note in its annual report, the company provides other healthcare services including laboratory testing. Located in Vake district, Tbilisi.
| Ratio | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|
| Margins | ||||||
| Gross Margin | 19.1% | 24.6% | 37.1% | 22.5% | 25.4% | 32.8% |
| EBITDA Margin | -5.0% | 13.9% | 23.8% | -1.9% | 5.1% | 14.4% |
| EBITDAR | -254 | 2,023 | 7,302 | -230 | 1,100 | 3,352 |
| EBITDAR Margin | -5.0% | 13.9% | 24.0% | -1.1% | 6.0% | 15.1% |
| EBIT Margin | -11.4% | 10.5% | 18.4% | -10.0% | -0.2% | 9.0% |
| Net Profit Margin | -22.4% | 7.7% | 16.1% | -12.7% | -6.4% | 6.1% |
| Operating Expense % of Sales | 24.1% | 10.7% | 13.4% | 24.4% | 20.4% | 18.4% |
| Returns | ||||||
| Return on Assets (ROA) | -6.0% | 4.0% | 15.5% | -10.2% | -4.2% | 4.7% |
| Return on Equity (ROE) | -9.7% | 8.4% | 26.3% | -15.8% | -7.5% | 7.8% |
| ROIC [EBIT / Invested Capital] | -3.6% | 8.8% | 27.7% | -10.5% | -0.1% | 8.2% |
| Leverage & debt balances | ||||||
| Debt-to-Assets | 22.5% | 28.1% | 14.8% | 16.5% | 22.6% | 25.5% |
| Debt-to-Equity | 0.36x | 0.59x | 0.25x | 0.26x | 0.40x | 0.43x |
| Debt-to-EBITDA | N/A | 3.93x | 0.65x | N/A | 6.72x | 2.31x |
| Equity-to-Assets | 61.8% | 47.5% | 59.0% | 64.6% | 55.9% | 59.4% |
| Net Debt | 4,229 | 4,033 | 1,545 | 3,055 | 6,051 | 7,186 |
| Cash & Equivalents | 50 | 3,896 | 3,142 | 1,141 | 239 | 200 |
| Total Debt | 4,279 | 7,929 | 4,687 | 4,196 | 6,290 | 7,386 |
| Liquidity & working capital | ||||||
| Current Ratio | 1.25x | 1.02x | 1.30x | 1.07x | 0.50x | 0.78x |
| Quick Ratio | 0.91x | 0.78x | 1.11x | 0.81x | 0.33x | 0.55x |
| Cash Ratio | 0.01x | 0.36x | 0.35x | 0.20x | 0.02x | 0.02x |
| Total Current Assets | 4,652 | 11,146 | 11,589 | 6,021 | 5,557 | 7,555 |
| Total Current Liabilities | 3,730 | 10,940 | 8,937 | 5,619 | 11,086 | 9,648 |
| Inventory | 1,267 | 2,617 | 1,635 | 1,456 | 1,846 | 2,237 |
| Trade Receivables | 1,319 | 3,109 | 6,117 | 3,147 | 2,779 | 3,797 |
| Trade Payables | 2,690 | 6,193 | 6,291 | 3,906 | 5,233 | 3,524 |
| Net Working Capital | 922 | 206 | 2,652 | 402 | -5,529 | -2,093 |
| Net Working Capital % of Revenue | 18.1% | 1.4% | 8.7% | 2.0% | -30.0% | -9.4% |
| Trade Working Capital | -104 | -467 | 1,461 | 697 | -608 | 2,510 |
| Trade Working Capital % of Revenue | -2.0% | -3.2% | 4.8% | 3.4% | -3.3% | 11.3% |
| Change in Trade Working Capital | N/A | -363 | 1,928 | -764 | -1,305 | 3,118 |
| Turnover & efficiency | ||||||
| Inventory Turnover | 3.26x | 4.19x | 11.72x | 10.88x | 7.45x | 6.66x |
| Days Inventory Outstanding (DIO) | 112.1 | 87.2 | 31.2 | 33.5 | 49.0 | 54.8 |
| Receivables Turnover | 3.87x | 4.67x | 4.98x | 6.50x | 6.63x | 5.84x |
| Days Sales Outstanding (DSO) | 94.4 | 78.1 | 73.3 | 56.2 | 55.0 | 62.5 |
| Payables Turnover | 1.53x | 1.77x | 3.04x | 4.06x | 2.63x | 4.23x |
| Days Payable Outstanding (DPO) | 237.9 | 206.3 | 119.9 | 90.0 | 139.0 | 86.3 |
| Cash Conversion Cycle | -31.5 days | -41.0 days | -15.4 days | -0.2 days | -34.9 days | 31.0 days |
| Asset Turnover | 0.27x | 0.51x | 0.96x | 0.80x | 0.66x | 0.77x |
| Cash flow & dividends | ||||||
| Operating Cash Flow | 11 | 2,030 | 5,904 | 35 | -1,329 | 234 |
| Free Cash Flow (OCF − Capex proxy) | -1,366 | 377 | 3,139 | -663 | -2,568 | -331 |
| Cash Conversion (OCF / EBITDA) | N/A | 100.6% | 81.3% | N/A | -142.0% | 7.3% |
| Dividends Declared | 0 | 0 | 0 | 0 | 0 | 0 |
| Dividend Payout Ratio | N/A | 0.0% | 0.0% | N/A | N/A | 0.0% |
Money rows — EBITDAR, net debt, cash, total debt, operating and free cash flow, dividends declared — are in GEL, thousands. Margins, returns and payout are percentages; turnover and leverage are multiples; DIO/DSO/DPO are days. Hover a metric name for its definition.
Shareholders, directors and group links from the companyinfo.ge public register — as filed, so stakes need not sum to 100% where a holding is undisclosed.
Ownership & directors from companyinfo.ge (public corporate registry).
Ranked by how close each latest revenue is to this one — not a curated comp set. Open this set in Compare →